Insider transactions

EDGAR

Brainstorm Cell Therapeutics Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–13 of 13

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-24 Filed 2026-07-28FRENKEL JACOB A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)100,0000.00
0

Derived: shares × price per share. Exact value 0.00.

343,777Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the Consulting Agreement) and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date.
Open filing 0001104659-26-087588 Read from the filing’s XML Dispute this row
2026-07-24 Filed 2026-07-28Pitts Peter Joe Director · Officer: Executive Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (900,000) — exercise price 1.00
Acquired (A)900,0000—900,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-087584 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-29FRENKEL JACOB A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)200,0000.00
0

Derived: shares × price per share. Exact value 0.00.

243,777Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-068336 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-29Lebovits Chaim Officer: President CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,800,0000.00
0

Derived: shares × price per share. Exact value 0.00.

2,000,960Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-068339 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-29Patlis Alla Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)100,0000.00
0

Derived: shares × price per share. Exact value 0.00.

144,349Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-068337 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-29ARBEL IRIT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)120,0000.00
0

Derived: shares × price per share. Exact value 0.00.

161,054Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-068335 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-29Yablonka Uri Director · Officer: EVP Chief Business Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)150,0000.00
0

Derived: shares × price per share. Exact value 0.00.

218,464Direct (D) No
F1
  • F1 Represents shares of restricted stock units (RSUs) awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-068338 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20Polverino Anthony J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (150,000) — exercise price 0.70
Acquired (A)150,0000.70
105,000

Derived: shares × price per share. Exact value 105000.00.

150,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064657 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20Naor Nir Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (180,000) — exercise price 0.70
Acquired (A)180,0000.70
126,000

Derived: shares × price per share. Exact value 126000.00.

180,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064652 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20HARTOUNIAN HARTOUN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (225,000) — exercise price 0.70
Acquired (A)225,0000.70
157,500

Derived: shares × price per share. Exact value 157500.00.

225,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064656 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20Bairu Menghisteab Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (150,000) — exercise price 0.70
Acquired (A)150,0000.70
105,000

Derived: shares × price per share. Exact value 105000.00.

150,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064658 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20Lindborg Stacy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (150,000) — exercise price 0.70
Acquired (A)150,0000.70
105,000

Derived: shares × price per share. Exact value 105000.00.

150,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064653 Read from the filing’s XML Dispute this row
2026-02-26 Filed 2026-05-20Dagher Ibrahim B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (225,000) — exercise price 0.70
Acquired (A)225,0000.70
157,500

Derived: shares × price per share. Exact value 157500.00.

225,000Direct (D) No
F1, F2
  • F1 Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
  • F2 The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
Open filing 0001104659-26-064650 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

No Schedule 13D or 13G naming this issuer is in the store; this is not a statement that none were filed.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to Brainstorm Cell Therapeutics Inc.